This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
.” In their methodology for curating this list, ECRI takes what they call a total systems safety (TSS) approach incorporating four pillars which together drive patient safety: Patient & family engagement Learning system Workforce safety & wellness, and, Culture, leadership, & governance.
This collaboration unites RadiusXRs innovative visual field platform and Topcon Healthcares global leadership in robotic diagnostics and digital healthcare solutions with Glaukos commitment to expanding patient access by democratizing the diagnosis of ophthalmic diseases such as glaucoma. .–(BUSINESS WIRE)–Topcon Healthcare, Inc.,
Believes Nymox Management and Board Must Be Held Accountable for Prolonged Underperformance and Egregious Governance Practices Urges Shareholders to Vote on the WHITE Proxy Card to Install New Leadership and a New Board at Upcoming Special Meeting CARSON CITY, Nev. & The Committee to Restore Nymox Shareholder Value, Inc.
CEO Transition Foster is an experienced C-Suite executive with a broad background in the healthcare, medical device, and pharmaceutical industries. Before joining CurvaFix, Foster was president and CEO of Trice Medical, a leader in the field of minimally invasive orthopedic procedures. Formerly he was V.P.
Onc.AI , a medicaltechnology company developing a novel digital clinical management solution focused on immuno-oncology, announced today it has closed a $25 million Series A financing co-led by MassMutual and Action Potential Venture Capital (a GSK venture fund). About Onc.AI.
To bolster this expansion, Vektor will increase clinical support and drive additional clinical studies to showcase the technology’s impact and inform future innovation as well as continue efforts to secure reimbursement. “At TVM also invests in differentiated commercial-stage medicaltechnologies and late clinical-stage therapeutics.
Healthcare providers, researchers, pharmaceutical companies, and medicaltechnology specialists will all need to take a phased approach to deploying new technologies. Integration and Regulation As with any form of broad-sweeping digital transformation, integration is key.
Seamless Therapeutics has a first-mover position with its innovative platform capable of modifying the long held standard recombination technology into a universal gene editing tool with unprecedented specificity. Forbion invests in life sciences companies that are active in the (bio) pharmaceutical space.
In addition to these core areas, there will likely be discussions on specific sectors within healthcare, such as pharmaceuticals, medical management, and healthcare delivery models. This could include discussions on healthcare disparities and strategies for achieving better health outcomes for all.
Post-acquisition, the Wilco Source leadership will run the integrated Salesforce business providing solutions and services across CitiusTech’s and Wilco Source’s existing and new clients. Risk Evaluation and Mitigation Strategies (REMS) solutions for pharmaceutical companies (Salesforce Health Cloud). About CitiusTech.
Mike King, Senior Director, Product and Strategy at IQVIA Increasing integration between quality, regulatory, and safety teams in pharmaceutical companies as well as the existing strong integrations in these departments in MedTech and IVD organizations.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content